search icon

    Market Snapshot

    • S&P Futures

      3,914.75

    • Dow Futures

      31,478

    • Nasdaq Futures

      12,132.75

    blog search icon

    AnaptysBio, Inc.

    (NASDAQ:ANAB)

    $22.62

    $0.17

    0.76%

    AnaptysBio, Inc. Chart

    ANAB Stock Price Today

    AnaptysBio, Inc. (ANAB) stock rallied over 0.76% intraday to trade at $22.62 a share on NASDAQ. The stock opened with a gain of 2.86% at $22.57 and touched an intraday high of $23.12, rising 0.76% against the last close of $22.45. The stock went to a low of $21.89 during the session.

    Stock Snapshot

    $22.45

    Prev. Close

    605.99 Million

    Market Cap

    $21.89

    Day Low

    $22.57

    Open

    27.71 Million

    Number of Shares

    $23.12

    Day High

    -

    P/E ratio

    -2.75

    EPS (TTM)

    19.81

    Cash Flow per Share

    19.04

    Free Float in %

    13.97

    Book Value

    178,449

    Volume

    AnaptysBio, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-23$22.57$23.12$21.89$22.62178,400
    2022-06-22$21.99$23.71$21.99$22.45316,400
    2022-06-21$21.49$23.35$21.098$22.34343,000
    2022-06-17$20.33$21.98$20.33$21.45531,300
    2022-06-16$21.24$21.242$20.3$20.39395,700
    2022-06-15$20.77$21.99$20.77$21.68553,800
    2022-06-14$21.23$21.435$20.57$20.8381,100
    2022-06-13$21.26$21.69$20.74$21.35277,700
    2022-06-10$22.3$22.775$21.44$22481,100
    2022-06-09$23.77$24.264$22.44$22.72363,300

    Contact Details

    10770 Wateridge Circle
    Suite 210
    San Diego, CA 92121-5801
    United States

    Webiste:ANAB

    858 362 6295

    Company Information

    Employees-

    Beta0.15

    Sales or Revenue63.17 Million

    5Y Sales Change30.50%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. The company's products include Imsidolimab, an IL-36R antibody that inhibits the interleukin-36 receptor for the treatment of various dermatological inflammatory diseases; ANB030, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through ANB030 treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. It also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. AnaptysBio, Inc. has a collaboration and license agreement with TESARO, Inc. and Celgene Corporation; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

    Frequently Asked Questions

    icon

    What is the current AnaptysBio, Inc. (ANAB) stock price?

    AnaptysBio, Inc. (NASDAQ: ANAB) stock price is $22.62 as of the last check on Thursday, June 23. During the trading session, ANAB stock reached the peak price of $23.12 while $21.89 was the lowest point it dropped to.

    icon

    ANAB's industry and sector of operation?

    The NASDAQ listed ANAB is part of Biotechnology industry that operates in the broader Health Care sector. AnaptysBio, Inc. , a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications.

    icon

    Who are the executives of ANAB?

    Mr. Hamza Suria
    Pres, CEO & Director
    Mr. Dennis M. Mulroy
    Chief Financial Officer
    Mr. Hamza Suria M.B.A., M.Sc.
    Advisory
    Dr. Paul F. Lizzul
    Chief Medical Officer

    icon

    What is the ANAB stock price today?

    ANAB stock traded closed the last session at $22.62, which is $0.17 or 0.76% lower than its previous close of $22.45. ANAB's current trading price is 24.29% lower than its 52-week high of $37.89 where as its distance from 52-week low of 18.20% is -40.30%.

    icon

    How many employees does ANAB have?

    Number of ANAB employees currently stands at -. ANAB operates from 10770 Wateridge Circle, Suite 210, San Diego, CA 92121-5801, United States.

    icon

    Link for ANAB official website?

    Official Webiste of $ANAB is: https://www.anaptysbio.com

    icon

    How do I contact ANAB?

    ANAB could be contacted at ANAB operates from 10770 Wateridge Circle, Suite 210, San Diego, CA 92121-5801, United States, or at phone #858 362 6295 and can also be accessed through its website.

    icon

    How many shares of ANAB are traded daily?

    ANAB stock volume for the day was 178,449 shares while in the previous session number of ANAB shares traded was 178,400 . The average number of ANAB shares traded daily for last 3 months was 346.74 Thousands.

    icon

    How much did ANAB change today?

    The percentage change in ANAB stock occurred in the recent session was 0.76% while the dollar amount for the price change in ANAB stock was $0.17.

    icon

    What price range ANAB stock been trading in?

    In the recent session, the day high for ANAB stock was $23.12 while the low for ANAB stock touched on the day was $21.89.

    icon

    What is the market cap of ANAB currently?

    The market value of ANAB currently stands at 605.99 Million with its latest stock price at $22.62 and 27.71 Million of its shares outstanding.